| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Monday - Jul 14, 2014 |
|||||||||
| Q2 FY14 | $1.27 | $1.08 | $19.43B | $16.45B |
NYSE |
||||
Wintrust Financial
WTFC
|
- | $0.76 | $0.71 | $201.65M | $189.92M |
NASDAQ |
|||
|
Bank OZK
OZK
|
- | $0.34 | $0.33 | $80.35M | $79.78M |
NASDAQ |
|||
|
Avid Bioservices
CDMO
|
Q4 FY14 | -$0.42 | -$0.47 | $6.47M | $7.24M |
NASDAQ |
|||
|
Saratoga Investment
SAR
|
- | $0.38 | $0.36 | $2.70M | $5.82M |
NYSE |
|||
|
Oramed Pharmaceuticals
ORMP
|
- | -$0.18 | -$0.15 | $379.01K | - |
NASDAQ |
|||
|
Pure Cycle
PCYO
|
- | -$0.02 | -$0.01 | $678.55K | $340K |
NASDAQ |
|||
